首頁 > 市場調查報告書 > 製藥

處方藥疼痛

止痛藥市場規模、佔有率和成長分析（按藥物類型、給藥途徑、應用、分銷管道和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1896033

止痛藥市場規模、佔有率和成長分析（按藥物類型、給藥途徑、應用、分銷管道和地區分類）—產業預測，2026-2033年

Analgesics Market Size, Share, and Growth Analysis, By Drug Type (Opioid Analgesics, Morphine), By Route Of Administration (Oral, Tablets), By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年止痛藥市場規模為 433.8 億美元，預計從 2025 年的 460 億美元成長到 2033 年的 734.2 億美元，在預測期（2026-2033 年）內複合年成長率為 6.02%。

全球止痛藥市場正經歷穩定成長，主要受以下幾個關鍵因素驅動：慢性疼痛疾病盛行率的上升和人口老化是推動市場需求的主要因素，同時人們對有效疼痛管理策略的認知也不斷提高。處方箋和非處方止痛藥因其緩解疼痛的有效性而備受青睞。此外，藥物輸送系統的進步、創新止痛藥配方的推出以及強大的學名藥研發管線也進一步推動了市場擴張。主要企業之間的策略聯盟和併購也發揮關鍵作用，增強了產品系列，並擴大了其在全球止痛藥市場的佔有率。這種動態的市場格局反映了全球止痛解決方案日益成長的重要性。

止痛藥市場促進因素

全球止痛藥市場的成長主要受慢性疼痛疾病發生率上升的推動。這些疾病影響著很大一部分人口，導致對有效止痛方案的需求不斷成長。關節炎、癌症、神經病變疼痛和肌肉骨骼疾病等都加劇了這一負擔。因此，人們迫切需要能夠緩解疼痛並改善患者生活品質的止痛藥物。此外，人們對疼痛管理重要性的認知不斷提高，加上藥物研發的進步，正在推動新型和改良止痛藥物的創新和開發，進一步促進市場擴張。

止痛藥市場的限制

全球止痛藥市場面臨的一大挑戰是某些止痛藥（尤其是鴉片類藥物）的副作用風險和潛在濫用問題。這些鴉片類藥物與成癮、成癮和過量用藥等問題密切相關，引發了嚴重的公共衛生擔憂。這導致監管審查力道加大，處方規範也更加嚴格。因此，醫療專業人員在開立鴉片類止痛藥時越來越謹慎，並鼓勵轉向非鴉片類替代藥物和替代性疼痛管理方法。如何在有效緩解疼痛和降低濫用風險之間取得平衡，是限制市場成長的一大障礙。

止痛藥市場趨勢

塑造全球止痛藥市場的關鍵趨勢是，由於人們對鴉片類藥物使用風險（包括成癮和過量服用風險）的認知不斷提高，非鴉片類止痛藥的需求日益成長。隨著醫護人員和患者尋求更安全的疼痛管理方案，他們開始轉向非鴉片類替代藥物，例如非類固醇消炎劑(NSAIDs) 和乙醯胺酚，這些藥物已被證明能有效緩解輕度至中度疼痛。這一轉變反映了人們越來越傾向於負責任的疼痛管理實踐，並推動了以安全性和有效性為優先的新型療法的研發創新。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline plc（GSK）
Sanofi SA
Bayer AG
Novartis AG
Merck & Co., Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
AbbVie Inc.
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Mylan NV
Endo Pharmaceuticals Inc.
Purdue Pharma LP
Mallinckrodt Pharmaceuticals
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Zydus Cadila

結論與建議

簡介目錄

Product Code: SQMIG35I2164

Analgesics Market size was valued at USD 43.38 Billion in 2024 and is poised to grow from USD 46 Billion in 2025 to USD 73.42 Billion by 2033, growing at a CAGR of 6.02% during the forecast period (2026-2033).

The global analgesics market is experiencing consistent growth, fueled by several key factors. A rising prevalence of chronic pain conditions and an increasing geriatric population are significantly driving demand, alongside a heightened awareness of effective pain management strategies. Both prescription and over-the-counter analgesics are witnessing heightened demand due to their effectiveness in alleviating discomfort. Moreover, advancements in drug delivery systems and the introduction of innovative analgesic formulations, alongside a robust pipeline of generic options, are propelling further market expansion. Strategic collaborations and mergers among major players also play a crucial role, enhancing product portfolios and broadening their global presence in the analgesics landscape. This dynamic landscape reflects the increasing prioritization of pain relief solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Analgesics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Analgesics Market Segments Analysis

Global Analgesics Market is segmented by drug type, route of administration, application, distribution channel and region. Based on drug type, the market is segmented into opioid analgesics and non-opioid analgesics. Based on route of administration, the market is segmented into oral, topical, injectable and transdermal. Based on application, the market is segmented into chronic pain, acute pain and other. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Analgesics Market

The global analgesics market is significantly driven by the rising incidence of chronic pain conditions, which impact a large segment of the population and create an increasing demand for effective pain relief solutions. Conditions such as arthritis, cancer, neuropathic pain, and musculoskeletal disorders all contribute to this escalating burden. Consequently, there is a pressing need for analgesic medications that can alleviate pain and enhance patients' quality of life. Additionally, the growing awareness regarding the importance of pain management, combined with advancements in pharmaceutical research, stimulates the innovation and development of new and improved analgesic drugs, further propelling market expansion.

Restraints in the Analgesics Market

A major challenge faced by the global analgesics market is the risk of side effects and the potential for misuse associated with certain analgesic medications, particularly opioids. These opioid-based drugs are linked to issues such as dependence, addiction, and overdose, raising serious public health concerns. This has resulted in heightened scrutiny from regulatory bodies and the establishment of more stringent prescription practices. As a consequence, healthcare providers are becoming increasingly cautious when it comes to prescribing opioid analgesics, which is fueling a transition towards non-opioid alternatives and different pain management methods. Balancing the demand for effective pain relief while reducing the risk of abuse presents a significant obstacle to market growth.

Market Trends of the Analgesics Market

A significant trend shaping the global analgesics market is the rising preference for non-opioid analgesics driven by heightened awareness of the dangers associated with opioid use, including addiction and overdose risks. As healthcare professionals and patients alike seek safer pain management options, there is an increasing focus on utilizing non-opioid alternatives such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, which are proving effective for alleviating mild to moderate pain. This shift reflects a broader movement towards responsible pain management practices and is fostering innovation in the development of new therapeutic agents that prioritize safety and efficacy.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies
Startup Analysis

Global Analgesics Market Size by Drug Type & CAGR (2026-2033)

Market Overview
Opioid Analgesics
- Morphine
- Fentanyl
- Oxycodone
- Hydrocodone
Non-Opioid Analgesics
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Ibuprofen
- Naproxen
- Aspirin
- Acetaminophen
- Compound Analgesics

Global Analgesics Market Size by Route Of Administration & CAGR (2026-2033)

Market Overview
Oral
- Tablets
- Capsules
- Liquids
Topical
- Creams
- Gels
- Patches
Injectable
- Intravenous
- Intramuscular
Transdermal

Global Analgesics Market Size by Application & CAGR (2026-2033)

Market Overview
Chronic Pain
- Arthritis
- Cancer Pain
- Neuropathic Pain
Acute Pain
- Postoperative Pain
- Injury Pain
Other
- Migraine
- Fibromyalgia

Global Analgesics Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Analgesics Market Size & CAGR (2026-2033)

North America (Drug Type, Route Of Administration, Application, Distribution Channel)
- USA
- Canada
Europe (Drug Type, Route Of Administration, Application, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Drug Type, Route Of Administration, Application, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Drug Type, Route Of Administration, Application, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Drug Type, Route Of Administration, Application, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (GSK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Purdue Pharma L.P.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Therapeutics plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Cadila
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments